Coronavirus vaccine: AstraZeneca boosts potential supply to 2bn
💡 One News Page Knowledge: Other News Mentions
Serum Institute CEO lauds PM Narendra Modi's COVID-19 vaccine vision day after challenging Centre on pandemic responseIt is to be noted that the Serum Institute of India is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford..
Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla asksOn September 16, the Drugs Controller General of India (DCGI) allowed the Serum Institute of India (SII) to restart its phase two and three clinical trials for..
Oxford vaccine's trial to start at Mumbai's KEM HospitalThe government-run KEM Hospital here on Saturday will administer, as part of human trial, Oxford University's Covishield vaccine for coronavirus to three..
AstraZeneca gets partial immunity in EU deal
Credit: Reuters Studio Duration: 01:25Published
Oxford Covid vaccine: AstraZeneca still waiting for FDA nod to resume US trialAstraZeneca is still waiting for the U.S. drug regulator to approve the restart of the clinical trial of its potential COVID-19 vaccine in the United States..
‘This is genocide’: Inside the bizarre rise of coronavirus conspiracy theoriesA weekday afternoon in Leeds city centre and a furious speaker is telling a crowd of 40 or so onlookers that coronavirus is a scam dreamed up by a shadowy cabal..
Bill Gates Outraged Over COVID Test Delays
Credit: Wochit News Duration: 00:25Published
Bill Gates: Losing Trust In FDA, CDC
Credit: Wochit News Duration: 00:33Published
Bill Gates Says Coronavirus Will End For Developed Nations by 2021
Credit: Cover Video STUDIO Duration: 01:29Published
Covid update: China allows Indians to return; Bill Gates on vaccine
Credit: HT Digital Content Duration: 02:44Published
You Might Like
Related videos from verified sources
Related news from verified sources
Tweets about this